Pancreatic Cancer Research

ResearcherThe Affiliated Yongchuan Hospital of Chongqing Medical UniversityActive in the last 2 years

Hongwei Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5842-5007; OpenAlex author ID A5115593349. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Extracellular Volume Derived from Equilibrium CT for the Prediction of Survival Outcomes in Patients with Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1177/15330338251336032↗
  2. Preoperative risk stratification of early recurrence in resected pancreatic ductal adenocarcinoma: Novel equilibrium-phase-computed tomography biomarker of ext… Last author DOI 10.3748/wjg.v31.i35.109687↗
  3. MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. Co-author DOI 10.1097/mpa.0000000000000677↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongmei Li · 2 shared papers, 2025 · strength 0.57
  2. Hongfan Liao · 1 shared paper, 2025 · strength 0.28
  3. Zhiwei Zhang · 1 shared paper, 2025 · strength 0.28
  4. Ju Xiong · 1 shared paper, 2025 · strength 0.28
  5. Hui Feng · 1 shared paper, 2016 · strength 0.07
  6. Jiaojiao Su · 1 shared paper, 2016 · strength 0.07
  7. Weiyan Yao · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.